ReviewFrontiers in pharmacology2026

A comparative review of economic evaluations for immune checkpoint inhibitors in early stage and advanced stage cancer: focusing on pembrolizumab.

Hyo-Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.